Virulence hierarchies within the <i>Mycobacterium tuberculosis</i> complex
Abstract
The Mycobacterium tuberculosis complex (MTBC) includes M. tuberculosis ( M. tb ), the primary cause of human tuberculosis, M. bovis, the classical zoonotic pathogen and cause of bovine tuberculosis, and M. orygis, a recently recognized multihost pathogen. Given that M. tb, M. bovis, and M. orygis pose significant threats to the health of humans and animals, we sought to understand fundamental differences in pathogenicity among these closely related organisms. Building upon historical observations, we conducted a comparative virulence assessment of these pathogens using both bovine and murine infection models. Holstein calves were infected via aerosol with M. tb, M. bovis, or M. orygis , and pathology was analyzed through macroscopic and microscopic assessments of lungs and lymph nodes, along with quantitative tissue bacterial burden measurements. In C57BL/6 mice, we compared virulence using three readouts, namely survival, lethal dose determination, and detailed pathological assessments. Despite genomic similarity, animal-adapted MTBCs consistently showed dramatically enhanced virulence compared to M. tb with distinct immunopathology and, in the murine model, mortality within 24 days. Using gene disruption studies guided by proteomic comparisons, we determined that these infection outcomes were dependent on shared (ESAT-6) and lineage-associated (MPT70) virulence factors, the route of infection, and prior infection or immunization. Our findings reveal unexpected virulence hierarchies within the MTBC, with fundamental and translational implications for tuberculosis research.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (18)
Sarah N. Danchuk
Department of Microbiology and Immunology, McGill University
Shannon C. Duffy
Department of Epidemiology of Microbial Diseases, Yale School of Public Health
Jaryd Sullivan
Department of Molecular Biology and Centre for Computational and Integrative Biology, Massachusetts General Hospital
Syed Beenish Rufai
Department of Neuroscience, University of Lethbridge
Fiona A. McIntosh
Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre
Andréanne Lupien
Department of Microbiology and Immunology, McGill University
Luke B. Harrison
Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre
Hojjat Ghasemi Goojani
Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre
Lorne Taylor
Infectious Disease and Immunity in Global Health Program, Research Institute of the McGill University Health Centre
Yuhong Wei
Goodman Cancer Institute, McGill University
Philippe Joubert
Rasmus Mortensen
Center for Vaccine Research, Department of Infectious Disease Immunology, Statens Serum Institut
Jeffrey M. Chen
Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan
Nirajan Niroula
Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan
Robin Stevens
Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan
Carla Norleen
Mycobacterial Pathogenesis and Tuberculosis Research Laboratory, Vaccine and Infectious Disease Organization, University of Saskatchewan
Vivek Kapur
Department of Animal Science and the Huck Institutes of the Life Sciences, The Pennsylvania State University
Marcel A. Behr
Department of Microbiology and Immunology, McGill University